CEO and President
Fri, Dec 16, 2022
Dec 16
20,113 shares @ $19.21
Decreased holdings by -50.30%
6th largest trade (out of 107)
Trade made by an officer
Unscheduled trade
Insider trade was 94% below market price
Price 39% above 200-day moving average
BTAIBioXcel Therapeutics, Inc.
HealthcareDrug Manufacturers - Specialty & Generic
1D0.00%
1W+5.34%
1M+24.89%
3M+21.05%
6M—
1Y—